NEW YORK (GenomeWeb News) – Applied BioCode is providing EraGen Biosciences access to its Barcoded Magnetic Bead technology and the CE-marked BioCode -1000 system under a partnership and licensing agreement announced today.
The technology provides a solution for development and clinical laboratory use of multiplexed infectious disease and genetic tests, Applied BioCode said. Its President, Winston Ho, added in a statement that the combination of his firm's technology with EraGen's patented chemistry is expected to result in a "powerful testing platform for clinical laboratories."
Financial and other terms of the deal were not disclosed.
"We look forward to commercializing molecular diagnostics that address not only customers needing real-time molecular testing, but also those in the growing segment that need highly multiplexed in vitro diagnostics," Irene Hrusovsky, chairperson and chief executive of EraGen, added.